Skip to main content
COCHLEAR LIMITED logo

COCHLEAR LIMITED — Investor Relations & Filings

Ticker · COH ISIN · AU000000COH5 LEI · 5493001OLLWY8KV5UC08 ASX Manufacturing
Filings indexed 1,424 across all filing types
Latest filing 2012-10-23 Regulatory Filings
Country AU Australia
Listing ASX COH

About COCHLEAR LIMITED

https://www.cochlear.com

Cochlear Limited designs, manufactures, and distributes implantable hearing solutions for individuals with moderate to profound hearing loss. The product suite includes cochlear implants, bone conduction systems, and acoustic implants, notably the Nucleus and Baha product lines. These technologies are engineered to bypass damaged parts of the ear to provide direct stimulation to the hearing nerve or bone. The company emphasizes research and development to advance sound processing capabilities, wireless integration, and miniaturization of components. Serving a global demographic from pediatric to geriatric patients, the organization provides long-term support and upgrades for its systems. Its focus remains on delivering high-performance hearing outcomes and enhancing the communication abilities of its recipients through technological innovation and clinical collaboration.

Recent filings

Filing Released Lang Actions
Appendix 3B 7 pages 42.6KB
Regulatory Filings
2012-10-23 English
Appendix 3B 7 pages 44.5KB
Regulatory Filings
2012-10-21 English
16/10/12 Chairmans AGM Address to Shareholders 6 pages 117.4KB
Regulatory Filings
2012-10-15 English
16/10/12 Cochlear AGM Presentation to Shareholders 24 pages 1.6MB
Regulatory Filings
2012-10-15 English
COH 2012 AGM - Results of Meeting 3 pages 52.8KB
Regulatory Filings
2012-10-15 English
Appendix 3B 7 pages 41.5KB
Regulatory Filings
2012-10-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.